Back to search
FDAFDA · Food and drugs·Recall number Z-1031-2013

Medtronic Prostiva RF Therapy Generator. The Prostiva RF system is indicated for the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men over the age of 50 with prostate sizes between 20 and 50 cm3.

Published April 10, 2013 · Recall initiated: February 27, 2013

Summary

FDA records medical device Class II recall Z-1031-2013, published April 10, 2013 and initiated February 27, 2013. Recalling firm: Medtronic Neuromodulation; Status: Terminated; Reported quantity: 848 (696 US, 152 OUS); Lot: all Model 8930 radio frequency (RF) generators are affected. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Medtronic has found through device testing that if the optional footswitch is not connected to the Model 8930 RF generator during use, an electrostatic discharge (i.e. static electricity) to the footswitch connector port may toggle the RF output on or off. If this were to occur, it could result in unintentionally starting or stopping the lesion process, depending on the current status of the equi

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Medtronic Neuromodulation
Distributor
Nationwide Distribution including Puerto Rico and all States in continental USA except ID, MT, and NH.
Lot
all Model 8930 radio frequency (RF) generators are affected
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Medtronic Prostiva RF Therapy Generator. The Prostiva RF system is indicated for the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men over the age of 50 with prostate sizes between 20 and 50 cm3. recalled?

Yes. FDA published recall Z-1031-2013 on April 10, 2013. Reported hazard: Medtronic has found through device testing that if the optional footswitch is not connected to the Model 8930 RF generator during use, an electrostatic discharge (i.e. static electricity) to the footswitch connector port may toggle the RF output on or off. If this were to occur, it could result in unintentionally starting or stopping the lesion process, depending on the current status of the equi

What should I do if I have this product?

Voluntary: Firm initiated · Letter